Croma-Pharma GmbH Stockerauerstrasse Korneuburg Tel.: +43 / (0)2262 / Fax: +43 / (0)2262 /
|
|
- Gordon Carr
- 6 years ago
- Views:
Transcription
1 Artikelnr.: AUSTRIA Headquarter Croma-Pharma GmbH Stockerauerstrasse Korneuburg Tel.: +43 / (0)2262 / Fax: +43 / (0)2262 / office@croma.at Subsidiaries Germany, France, Poland, Romania, Spain, Switzerland, Hungary
2 Synocrom forte Innovations With Synocrom forte, Croma-Pharma introduces an innovative intra-articular viscosupplementation therapy which combines traditional therapeutic benefits of hyaluronic acid substitution with an accelerated mode of action and fewer injections. 2% hyaluronic acid of biofermentative origin Significant pain reduction 120 mg hyaluronic acid per treatment cycle Rapid therapeutic effect Only 3 injections For all synovial joints
3 Synocrom forte biochemical characteristics 2% hyaluronic acid Biofermentative origin Patented stabilization process Improved thermo stability High viscosity 2.1 million dalton Synocrom forte technical properties Pre-filled syringe 2 ml filling volume Hard-cover blister Luer lock Terminal steam sterilization
4 Indications Synocrom forte is an intra-articular viscosupplementation 3) product intended for the treatment of osteoarthritis of all synovial joints. Approved therapeutic indications include: Gonarthritis Coxarthritis Omarthritis Ankle arthritis Arthritis of the elbow
5 Rapid and long-lasting therapeutic effect A post-market surveillance study 4) assessing 115 patients showed that one Synocrom forte treatment cycle provides pain relief for up to 12 months. Synocrom forte contains 2% hyaluronic acid of biofermentative origin, which is stabilized in a patented procedure. VAS long-lasting therapeutic Effect Thanks to its high concentration of hyaluronic acid and the creation of a three-dimensional HA network, Synocrom forte ensures rapid pain relief which lasts up to 12 months. 4) 1. injection 2. injection 3. injection 1 month 2 months 3 months 4 months 5 months 6 months pain during therapy pain at follow-up 7 months 8 months 9 months 10 months 11 months 12 months Synocrom forte is particularly well suited for the treatment of of osteoarthritis grade III. Even in severe cases a long-lasting VAS reduction of more than 30 mm is achieved, which can last for up to 12 months.
6 Excellent patient satisfaction A post-market surveillance study 4) assessing 115 patients revealed excellent patient satisfaction. 80% of all patients treated with Synocrom forte confirm its excellent efficacy within the first 6 months after therapy completion. % ratings assessment of patient satisfaction % of all patients treated with Synocrom forte still confirm its excellent efficacy 12 months after therapy completion SYNOCROM forte months after last injection 80% of all surgeons confirm the excellent efficacy of Synocrom forte throughout the entire therapy. 4) 10
7 2% hyaluronic acid of biofermentative origin Synocrom forte pre-filled syringes contain 2% hyaluronic acid of biofermentative origin. Thus, Synocrom forte contains twice as much active substance compared to main competitive products. 5) Brand name Synocrom forte Synvisc Hyalgan Suplasyn Manufacturer Croma-Pharma Genzyme Fidia Bioniche Source Biofermentative Rooster combs Rooster combs Biofermentative Concentration 2% Hyaluronic acid 0.8% Hylan 1% Hyaluronic acid 1% Hyaluronic acid Amount of hyaluronic acid/treatment cycle 120 mg 48 mg 100 mg 100 mg Molecular weight 2.1m. Da. 6 m. Da. (average) kda kda. Number of injections
8 Improved stability in the joint Due to its hyaluronic acid stabilization process and the slower enzymatic degradation, Synocrom forte shows higher thermo stability at 40 C in vitro 4) and better stability in the synovial joint than native 2% hyaluronic acid. viscosity mpa. s effect of cross-linkage 100,000 80,000 60,000 40,000 20, weeks SYNOCROM forte native 2% hyaluronic acid 15
9 Viscosity Synocrom forte has outstanding shock-absorbing and friction reducing properties due to its excellent viscosity, which is 10 times higher than in conventional 1% non-stabilized hyaluronic acid products. mpa. s viscosity 80,000 70,000 77,250 60,000 50,000 40,000 30,000 20,000 10,000 0 SYNOCROM forte 6,060 1% HA 16
10 Croma-Pharma quality characteristics Hyaluronic acid of biofermentative origin Croma-Pharma places great emphasis on the safety and purity of its products. We carefully select our raw materials, choosing only hyaluronic acid of biofermentative origin which does not contain any traces of animal proteins or prions. Our products are manufactured according to strict safety guidelines at our high-tech production site in Austria. In this way we provide our customers with pure, sterile and pyrogen-free viscoelastic solutions of highest quality. 18
11 Croma-Pharma quality characteristics Sterilization Terminal steam sterilization of the product guarantees inner and outer sterility of the syringe. This special sterilization method guarantees a sterility grade of the syringe which is 1,000 times higher compared to conventional methods, e.g. aseptic filling. Thus, terminal steam sterilization is an essential part of our commitment to safety. All Croma-Pharma products are steam- and heat- sterilized and offer a sterility assurance level (SAL) of 10-6, i.e. all of our products are suitable for surgery. 19
12 Croma-Pharma quality characteristics Transparent quality control process All of our products are manufactured according to GMP guidelines and ISO standards. The sterility and quality of our hyaluronic acid products are tested on a regular basis by an accredited microbiologic institute (Austrian Agency for Health and Nutrition, Graz). 20
Consumer Health Care V5.0_2013
Consumer Health Care Headquarters ProNovis GmbH Infanteriestr. 19/6 80797 Munich Germany Tel: +49 / 89 / 326676-30 Fax: +49 / 89 / 326676-35 www.pronovis.net info@pronovis.net Mission and Vision ProNovis
More informationSODIUM HYALURONATE 2% + MANNITOL. Flexible Treatment Scheme
SODIUM HYALURONATE 2% + MANNITOL Flexible Treatment Scheme INNOVATIVE PATENTED FORMULATION 1 Intra-articular hyaluronic acid (HA) has an established place in the symptomatic treatment of osteoarthritis
More informationPost-Market Surveillance Study. SYNOCROM forte in Gonarthritis
A-1070 Vienna, Kaiserstraße 84 Tel.: (1) 524 61 78 Fax: (1) 524 61 78/22 Email: mail@heinz-consulting.com Post-Market Surveillance Study SYNOCROM forte in Gonarthritis in December 2007 Commissioned by:
More informationJOYFLEX complete OA line
JOYFLEX complete OA line NEW Patent formulation* HA 1,6% HA 2,0% *PCT pending What s Osteoarthritis Sometimes called degenerative joint disease or degenerative arthritis, osteoarthritis (OA) is the most
More informationSODIUM HYALURONATE 2% + MANNITOL. Flexible Treatment Scheme
SODIUM HYALURONATE 2% + MANNITOL Flexible Treatment Scheme 56433 TRB Brochure.indd 1 15/12/2009 12:31 INNOVATIVE PATENTED FORMULATION 1 Intra-articular hyaluronic acid (HA) has an established place in
More informationImportant facts about ORTHOVISC mini
ORTHOVISC mini A targeted treatment for small joint pain. An increasing number of patients suffer from osteoarthritis (OA), the multisymptomatic joint disease characterized by cartilage degeneration and
More informationHyaluronic Acid Derivatives
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.09 Subject: Hyaluronic Acid Derivatives Page: 1 of 6 Last Review Date: December 2, 2016 Hyaluronic
More informationLine, Designed for. long-term relief in OA
New packaging design Printed in 05/11 The new Ostenil presentation may not yet be available in your country. Please contact your local distributor for further information. Ostenil Line, Designed for long-term
More informationHyaluronic Acid Derivatives
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.09 Subject: Hyaluronic Acid Derivatives Page: 1 of 6 Last Review Date: March 20, 2015 Hyaluronic Acid
More informationRestore Tendon Function (UK ) L
Restore Tendon Function (UK ) L OSTENIL TENDON helps to maintain tendon biomechanical properties OSTENIL TENDON contains a solution of hyaluronic acid which has unique properties: Acts as a lubricant
More informationnatural balance science nature. between and
natural balance A science between nature. and ORTHOVISC : Close to High Molecular Weight Hyaluronan Orthovisc : Closely matches healthy synovial fluid. 0.6 1.9 1.4 OA of the knee 1,2 1-2.9 60 46 ORTHOVISC
More informationHyaluronic Acid Derivatives
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.75.09 Subject: Hyaluronic Acid Derivatives Page: 1 of 6 Last Review Date: March 16, 2018 Hyaluronic Acid
More informationRegain your freedom. Authorised Representative Genzyme Europe B.V. Gooimeer DD Naarden The Netherlands
Regain your freedom Authorised Representative Genzyme Europe B.V. Gooimeer 10 1411 DD Naarden The Netherlands Genzyme Limited 4620 Kingsgate Cascade Way Oxford Business Park South Oxford OX4 2SU Tel: 01865
More informationHyaluronic Acid Derivatives
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.11.04 Subject: Hyaluronic Acid Page: 1 of 6 Last Review Date: March 13, 2014 Hyaluronic Acid Derivatives
More informationBreakthrough treatment for pain in Osteoarthritis of the joints. A Patient s Guide
Breakthrough treatment for pain in Osteoarthritis of the joints A Patient s Guide Your doctor has recommended treatment with HYMOVIS (Hyadd4) for your osteoarthritis joint pain. This guide is intended
More informationHealth Care Technology. Press Kit. Contact: Ms. Lucijana Manovic Sales/Marketing. Tel.: +43 (0)
Press Kit Contact: Ms. Lucijana Manovic Sales/Marketing Tel.: +43 (0) 316 42 65 00-10 E-Mail: lucijana.manovic@mides.com Index 1. The Company... 3 2. Facts and Figures... 4 3. Products and Services...
More informationDECREASE JOINT PAIN IMPROVE JOINT FUNCTION Treatment of Osteoarthritis with Ostenil
PATIENT - INFORMATION DECREASE JOINT PAIN IMPROVE JOINT FUNCTION Treatment of Osteoarthritis with Ostenil What is osteoarthritis? Osteoarthritis is a degenerative joint disease that mainly occurs due to
More informationA Patient s Guide to Viscosupplementation for Osteoarthritis of the Knee
A Patient s Guide to Viscosupplementation for Osteoarthritis of the Knee Iain is a specialist in musculoskeletal imaging and the diagnosis of musculoskeletal pain. This information is provided with the
More informationINTRA-ARTICULAR HYALURONAN INJECTIONS
INTRA-ARTICULAR HYALURONAN INJECTIONS Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Viscosupplementation for Osteoarthritis Table of Contents Coverage Policy... 1 General Background... 4 Coding/Billing Information... 8 References... 8 Effective
More informationIs Viscosupplementation Effective in Reducing Osteoarthritis Knee Pain?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2016 Is Viscosupplementation Effective in
More informationPowerful and Long-lasting Pain Relief
Powerful and Long-lasting Pain Relief A single-injection hyaluronic acid (HA) treatment that has proven: Greater reduction in knee pain vs. Synvisc-One (hylan G-F 20) 1 Longer-lasting knee pain relief
More informationThe Use of Viscosupplementation in FDA-Approved & Non FDA-Approved Joints
The Use of Viscosupplementation in FDA-Approved & Non FDA-Approved Joints Ramon Cuevas-Trisan, MD Disclosure Consultant/Speakers Bureau: Allergan Speakers Bureau: Ipsen, Merz 1 Learning Objectives Describe
More information2/28/2017. The Use of Viscosupplementation in FDA-Approved & Non FDA-Approved Joints. Disclosure. Learning Objectives
The Use of Viscosupplementation in FDA-Approved & Non FDA-Approved Joints Ramon Cuevas-Trisan, MD Chief, Physical Medicine, Rehabilitation & Pain Management West Palm Beach VAMC Disclosure Nothing to disclose
More informationHOSPITAL INNOVATIONS
idente Catalogue About HOSPITAL INNOVATIONS Since 2008, Hospital Innovations has been supplying a growing range of specialist products for use in orthopaedic and corrective surgery; with an emphasis on
More informationNEW CHONDROITIN (CS 2%) HYALURONATE (HA 2%) EXCELLENT ANTERIOR CHAMBER STABILITY, LUBRICATING PROPERTIES & EFFICIENT REMOVAL
High-Performing Viscoelastic VISCO DISPERSIVE NEW CHONDROITIN (CS 2%) HYALURONATE (HA 2%) DESCRIPTION : IXIUM HCS is a visco-elastic high molecular weight solution of a non-inflammatory, highly purified
More informationARBOCEL. Natural Raw Fibre Concentrates. Innovative Raw Fibre Concentrates for successful petfood products. J. RETTENMAIER & SÖHNE Fibres designed
ARBOCEL Innovative Raw Fibre Concentrates for successful petfood products J. RETTENMAIER & SÖHNE Fibres designed by Nature GMBH+CO.KG ARBOCEL ARBOCEL - multifunctional Raw Fibre Concentrate What is ARBOCEL?
More informationSTRENGTH FOR LIFE BONE CEMENTS FOR VERTEBRAL CONSOLIDATION
STRENGTH FOR LIFE BONE CEMENTS FOR VERTEBRAL CONSOLIDATION who we are G-21 was set up in 2009 by expert entrepreneurs originating from the medical and pharmaceutical sector. G-21 is situated in proximity
More informationHylans are degraded in the body by the same pathway as hyaluronan, and breakdown products are nontoxic.
SYNVISC (HYLAN G-F 20) 2 ml AND SYNVISC-ONE * (HYLAN G-F 20) 6 ml INSTRUCTIONS FOR USE DESCRIPTION Synvisc / Synvisc-One (hylan G-F 20) is a sterile, nonpyrogenic, elastoviscous fluid containing hylans.
More informationBone augmentation with biomaterials
Patient information dental bone & tissue regeneration botiss biomaterials Bone augmentation with biomaterials established safe natural X100 Implantation stability is crucial for success Atrophy of the
More informationGreater Manchester EUR Policy Statement
Greater Manchester EUR Policy Statement Title/Topic: Hyaluronic Acid Injections for Osteoarthritis Date: June 2014 Last Reviewed: May 2015 Reference: GM037 VERSION CONTROL Version Date Details Page number
More informationViscosupplementation for Osteoarthritis
Viscosupplementation for Osteoarthritis DRUG POLICY BENEFIT APPLICATION Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions,
More informationOstenil. Range. Reducing Pain Improving Function (UK) L
Ostenil Range Reducing Pain Improving Function (UK) L Flexible treatment scheme with high dose HA 2% Mannitol-stabilised HA. Mannitol acts as a free radical scavenger which protects HA from rapid depolymerisation.
More informationYour doctor will inject Synvisc-One into your knee.
PATIENT INFORMATION Be sure to read the following important information carefully. This information does not take the place of your doctor s advice. If you do not understand this information or want to
More informationDRIVING THE FUTURE. About HOSPITAL INNOVATIONS. Strong commitment to healthcare innovation
idente Catalogue About HOSPITAL INNOVATIONS Since 2008, Hospital Innovations has been supplying a growing range of specialist products for use in orthopaedic and corrective surgery; with an emphasis on
More informationCyBio Felix Your Automated Application Starts Here
Title Label Lab Automation CyBio Felix Your Automated Application Starts Here 2 CyBio FeliX Future-Proof Liquid Handling Automation Transform your manual workflows to automated processes on your benchtop!
More informationUSA Product Label LEGEND / LEGEND MULTI DOSE. (hyaluronate sodium) Injectable Solution LEGEND MULTI DOSE. (hyaluronate sodium) Injectable Solution
USA Product Label http://www.vetdepot.com BAYER HEALTHCARE LLC Animal Health Division P.O. BOX 390, SHAWNEE MISSION, KS, 66201-0390 Customer Service Tel.: 800-633-3796 Customer Service Fax: 800-344-4219
More informationProtocol. Intra-Articular Hyaluronan Injections for Osteoarthritis
Protocol Intra-Articular Hyaluronan Injections for Osteoarthritis (20131) Medical Benefit Effective Date: 04/01/17 Next Review Date: 01/19 Preauthorization No Review Dates: 01/13, 01/14, 01/15, 01/16,
More informationJoint Preservation And Biologic Program
SPORTS INSTITUTE Joint Preservation And Biologic Program The latest and most innovative treatment options available today for a multitude of orthopaedic injuries and pathologies Ellis and Badenhausen Sports
More informationCompany Overview January 2018
Company Overview January 2018 Our vision We are a leading family-owned pharmaceutical company in Austria that aims to expand this leading role in other European OTC markets. 2 Phyto-expertise "The most
More informationTETEC the cartilage makers
Powered by Website address: https://www.gesundheitsindustriebw.de/en/article/news/tetec-the-cartilage-makers/ TETEC the cartilage makers What you need is patient cells. The certified laboratories of TETEC
More informationJoint Injections Why are joint injections performed? Does joint arthritis benefit from injections?
Joint Injections Why are joint injections performed? Joints in the human body consist of articular cartilage. Normally, cartilage surfaces in joints provide a frictionless surface to provide range of motion
More informationRheological Study of Healthy and Pathological Synovial Fluid after Surgery for Repair of Rupture of the Cranial Cruciate Ligament of Dogs
ANNUAL TRANSACTIONS OF THE NORDIC RHEOLOGY SOCIETY, VOL. 6, 2008 Rheological Study of Healthy and Pathological Synovial Fluid after Surgery for Repair of Rupture of the Cranial Cruciate Ligament of Dogs
More informationIntra-Articular Viscosupplementation With Hylan G-F 20 To Treat Osteoarthritis of the Knee
Ontario Health Technology Assessment Series 2005; Vol. 5, No. 10 Intra-Articular Viscosupplementation With Hylan G-F 20 To Treat Osteoarthritis of the Knee An Evidence-Based Analysis June 2005 Medical
More informationAGRANA STARCH CONSTRUCTION CHEMICALS AND ADDITIVES
AGRANA STARCH CONSTRUCTION CHEMICALS AND ADDITIVES AGRANA STARCH AGRANA STARCH is a wholly owned subsidiary of the AGRANA Holding AG, the holding company of the Austrian sugar and starch industry. The
More informationThe cellfree matrix for autoregeneration of articular cartilage defects
The cellfree matrix for autoregeneration of articular cartilage defects What is Amedrix GmbH? Amedrix GmbH, located in Esslingen near Stuttgart, is a medical biotech company which develops highly innovative
More informationKey Clinical & Pre-clinical Resource Guide
Key Clinical & Pre-clinical Resource Guide Clinical 1. Study Title NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial Leighton
More informationWhy Choose OriGen? Mission Statement: We create medical products which improve peoples lives.
Accessory Catalog S-FFP12 Mission Statement: We create medical products which improve peoples lives. Why Choose OriGen? Quality Commitment quality is the foundation of all product design at OriGen, and
More informationLet s share our talents
Let s share our talents 2 The global solution in dental implantology As the first dental implant provider to develop a comprehensive offer, Anthogyr designs, manufactures and distributes a complete range
More informationJOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS Vol. 31, no. 4, (2017)
JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS Vol. 31, no. 4, 1139-1145 (2017) LETTER TO THE EDITOR SAFETY AND TOLERABILITY OF INTRA-ARTICULAR HYALURONIC ACID (SINOVIAL /GELSYN-3 TM ) INJECTIONS
More informationCorporate Medical Policy
Corporate Medical Policy Intra Articular Hyaluronan Injections for Treatment of Osteoarthritis of File Name: intra_articular_hyaluronan_injections_for_treatment_of _osteoarthritis_of_the_knee Origination:
More informationBIO-PLUS CROSS-LINKED HYALURONIC ACID. Mono-phase treatment for degenerative and trauma-caused diseases in all joints.
CROSS-LINKED HYALURONIC ACID Mono-phase treatment for degenerative and trauma-caused diseases in all joints. REGENFLEX BIO-PLUS Cross-linked Hyaluronic Acid The treatment is based on cross-linked and free
More informationMaxigen Biotech Inc. Integrity, passion and professionalism are not just promises to our customers, but also commitments we make to ourselves.
Maxigen Biotech Inc. Integrity, passion and professionalism are not just promises to our customers, but also commitments we make to ourselves. 1 Company profile Company name Maxigen Biotech Inc. (MBI)
More informationFairmont Dubai Sheikh Zayed Road Dubai United Arab Emirates
Fairmont Dubai Sheikh Zayed Road Dubai United Arab Emirates abdul@wellnessbywow.com +971 4 311 6579 Company Profile Pinnacle Tower Office xxx Al Barsha Dubai United Arab Emirates abdul@wellnessbywow.com
More informationFree Trial Future Generics Database
API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide
More informationVitamin D. » Abnormal metabolism of calcium (refl ected by. » Cystic fi brosis and Crohn disease, infl ammatory bowel. » Kidney transplantation
Analytical Reference Standards 2016/05 Vitamin D In order to support the growing need of clinical and medical laboratories looking for high quality and reliable reference standards for performing Vitamin
More informationTHAT S PROVEN FOR THE LONG RUN
A GUIDE FOR PATIENTS KNEE PAIN RELIEF THAT S PROVEN FOR THE LONG RUN TREATMENT OPTIONS FOR OA KNEE PAIN There are several things you can do to help reduce knee pain due to OA. Lifestyle changes Losing
More informationInnovator in Chelated Mineral Nutrition
Leader The World & Innovator in Chelated Mineral Nutrition 2011 Albion Human Nutrition. All rights reserved. Albion Manufacturing Technologies, Ogden Utah Albion Central Warehouse, Ogden Utah Albion Corporate
More informationAnnual Figures 2017/18. Burgdorf, 24 May 2018
Annual Figures 2017/18 Burgdorf, 24 May 2018 Important information The information contained in this document has not been verified by an independent source. It should be taken with caution and no assurance
More informationHARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION
HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION 2 3 QUALICAPS HISTORY Over one hundred years of experience in the manufacturing and filling of hard two-piece capsules Qualicaps
More informationA GUIDE FOR PATIENTS KNEE PAIN RELIEF THAT JUST CAN T WAIT
A GUIDE FOR PATIENTS KNEE PAIN RELIEF THAT JUST CAN T WAIT TREATMENT OPTIONS FOR OA KNEE PAIN There are several things you can do to help reduce knee pain due to OA. Lifestyle changes Losing weight, if
More informationEster Base Stocks for Marine Lubricants
The definition of EAL s that the EPA has adopted includes amongst others the widely accepted European Eco Label (EEL). The EEL defines strict standard for ecotoxicoty, environmental acceptance and renewability.
More informationBONE SUBSTITUTION SPECIAL MEMBRANES SCREWS RIVETS
BONE SUBSTITUTION SPECIAL MEMBRANES SCREWS RIVETS 1 Introduction About the company 2 Technology and quality 3 Applied raw materials 5 BIONIKA Titanium membrane meshes Titanium membranes Special membrane
More informationArthrocentesis and viscosupplementation as treatment modalities for arthralgia of the temporomandibular joint Vos, Lukas Matthijs
University of Groningen Arthrocentesis and viscosupplementation as treatment modalities for arthralgia of the temporomandibular joint Vos, Lukas Matthijs IMPORTANT NOTE: You are advised to consult the
More informationMistakes people make. when seeing a doctor for osteoarthritis knee pain.
5 Mistakes people make when seeing a doctor for osteoarthritis knee pain. Are you sabotaging your own chances for having a successful appointment about your knee pain? Avoid these common mistakes to get
More informationProduct Information for Labs. etkon ident Perfectly versatile. Performance you can rely on.
Product Information for Labs etkon ident Perfectly versatile. Performance you can rely on. BENEFIT FROM THE BEST OF BOTH WORLDS Versatility Simplicity Industry-leading manu facturing standards Variety
More informationThe medicines you are using mixed with Water for injections may interact with each other.
PACKAGE LEAFLET: INFORMATION FOR THE USER solvent for parenteral use Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this
More informationLeader in custom manufacturing. for the pharmaceutical and nutraceutical industries.
Leader in custom manufacturing for the pharmaceutical and nutraceutical industries. Since its inception in April 1994, Viva Pharmaceutical Inc. has built a reputation as a leading manufacturer committed
More informationJOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER
Food for Thought JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER CLINOPS DAG, 12 APRIL 2018 HISTORY OF RESEARCH AND DEVELOPMENT
More informationROX-CERA CERID TITANIUM-ZIRCONIUM CERAMIC DREIFACH EIN STARK
ROX-CERA CERID TITANIUM-ZIRCONIUM CERAMIC ROX-CERA STRONG WIE CONNECTIONS DREIFACH EIN STARK DISCOVER ROX-CERA Innovative ceramic surface Wider range of indications Enhances patient compliance 2 A STRONG
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Intra-Articular Hyaluronan Injections for Osteoarthritis Page 1 of 16 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Intra-Articular Hyaluronan Injections for Osteoarthritis
More informationIntra-articular Hyaluronan Injections for Osteoarthritis
Intra-articular Hyaluronan Injections for Osteoarthritis Policy Number: 2.01.31 Last Review: 01/2018 Origination: 02/2006 Next Review: 02/2019 Policy Intra-articular hyaluronan injections of the knee are
More informationTable 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter
AMM-Q269 Ver.7 Page 2 of 5 Table 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter Product name STRIDESMOOTH (Stride) Model No. STD105-22S STD125-22S STD125-22A STD130-22S STD150-22S STD105-26S
More informationo Total knee arthroplasty is projected to grow 85% o Other studies predict up to 3.48 million TKA o 17% adults over age 45 have symptomatic OA
NONOPERATIVE TREATMENT OF KNEE ARTHRITIS DAVID M SCHALL MD Knee Arthritis o Total knee arthroplasty is projected to grow 85% to 1.26 million procedures per year by 2030 o Other studies predict up to 3.48
More informationFlexi-Needles. BMI_FLEXINEEDLES_v2 web
Flexi-Needles BMI_FLEXINEEDLES_v2 _ _web Best Medical can provide any standard or customized configuration made to your exact specifications, sterile or non-sterile, shipped within 24 hours worldwide!
More informationDUROLANE: The Science of the Single Injection
: The Science of the Single Injection is a stabilised, hyaluronic acid (HA)-based, viscoelastic gel for the intra-articular treatment of mild to moderate osteoarthritis of the knee and hip. is different
More informationDraft Guidance for Industry and FDA Staff
Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document
More informationTHE BEST TIME IS NOW.
THE BEST TIME to tackle osteoarthritis knee pain IS NOW. 1. TAKE ACTION 2. Consider synvisc-one Synvisc-One (hylan G-F 20) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients
More informationab Red Blood Cell (RBC) Lysis Buffer
ab204733 Red Blood Cell (RBC) Lysis Buffer Instructions for Use For the lysis of red blood cells. This product is for research use only and is not intended for diagnostic use. Version 2 Last Updated 8
More informationViscosupplementation: What is the evidence for hyaluronic acid intra-articular injections?
DRUG NEWS Viscosupplementation: What is the evidence for hyaluronic acid intra-articular injections? BOTTOM LINE: There is a lack of quality evidence to support or refute the use of HA intra-articular
More informationThe solid choice for Omega-3
The solid choice for Omega-3 The highest-load powder in its class. Superior bioavailability, stability and compressibility. Enabling smaller, simpler and more satisfying supplements. Unmatched properties
More informationPre-Op Planning for your knee replacement surgery
Pre-Op Planning for your knee replacement surgery Are You Considering Knee Replacement Surgery? Knee pain can be the result of injury, biomechanical problems, or disease. When stiffness and pain in your
More informationBrachytherapy Kits. BMI_BRACHYKITS_v17_ _web. Luer Lock Obturator Suture Holes Outer Catheter. Outer Catheter. Radioactive Seed.
Brachytherapy Kits Luer Lock Obturator Suture Holes Outer Catheter Filament Inner Catheter Stem Flexible Button Outer Catheter Radioactive Seed Spacer New Flexible Silicone Button with 8 Holes BMI_BRACHYKITS_v17_11112013_web
More informationIsn t it worth two bags?
Isn t it worth two bags? NEW from Miltenyi Biotec CryoMACS Freezing Bag CryoMACS Freezing Bag Designed for freezing and cryopreservation of blood components Overwrap bag protects both sample and freezing
More informationTHE POLYKEMI GROUP ENGLAND A WORLD CLASS COMPOUNDER
THE POLYKEMI GROUP ENGLAND A WORLD CLASS COMPOUNDER A world class compounder. Within the Polykemi Group we have never had nor do we have any aspirations to become one of the largest multinational plastic
More informationPreparation Instructions for the CAMLOG /CONELOG Implant System
J8000.0032 Rev.6 EN 06/2015 Preparation Instructions for the CAMLOG /CONELOG Implant System ENGLISH The following descriptions contain detailed instructions on cleaning, disinfection and sterilization
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ISO/IEC 17021-1:2015 to provide quality management systems Davy Avenue Knowhill Milton Keynes MK5 8NL Contact: Dr Eugene Kotlirov Tel: +44
More informationNon-Operative Options for Articular Cartilage Issues in the Athlete s Knee
Non-Operative Options for Articular Cartilage Issues in the Athlete s Knee Sourav Poddar, MD Associate Professor Director, Primary Care Sports Medicine University of Colorado School of Medicine OBJECTIVES
More informationOverview of European Consumption Databases
FEDERAL INSTITUTE FOR RISK ASSESSMENT Overview of European Consumption Databases Katrin Büsch Workshop Food Consumption Data and Dietary Exposure in the European Union, 15-16 May 2008, Berlin Introduction
More informationOSTEOARTHRITIS: WHY IT S A PAIN IN THE KNEE & WHAT YOU CAN DO ABOUT IT
OSTEOARTHRITIS: WHY IT S A PAIN IN THE KNEE & WHAT YOU CAN DO ABOUT IT What every patient should know before considering surgery or treatment for their osteoarthritis knee pain. Inside You Will Discover:
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationWebinar 2. Natures Aid: Joint Health
Webinar 2 Natures Aid: Joint Health The Scale of The Problem Joint problems such as osteoarthritis affect many millions of people throughout the world, leading to agonising pain and disability. Arthritis
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): March 25, 2014 Effective Date: April 01, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationNoticeably improved mobility Markedly less joint pain Comprehensive care by your doctor Many years of experience
1 Your personal treatment plan. Recosyn Your advantage in the treatment of arthrosis. Recosyn Your advantage in the treatment of arthrosis. 2 3 4 Noticeably improved mobility Markedly less joint pain Comprehensive
More informationClinical studies with Viscoseal following arthroscopic surgery
Clinical studies with Viscoseal following arthroscopic surgery Clinical studies with Viscoseal in arthroscopic surgery (442 patients) Shoulder Funk L. et al. 9 th OARSI Congress. 2004 (poster) (58 patients)
More informationRisk Classification of Excipients. Presentation to Stakeholders Meeting Brussels 14 th May 2009 Frithjof Holtz
Risk Classification of Excipients Presentation to Stakeholders Meeting Brussels 14 th May 2009 Frithjof Holtz Risk Classification of Excipients 1. Why Classification? 2. How will Classification work? 3.
More informationR&D Status in Romania
R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;
More informationTHE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability
THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability International Federation of Pharmaceutical Manufacturers & Associations THE COMPLEX JOURNEY
More informationBecause you care about CONSUMERS HEALTH
Because you care about CONSUMERS HEALTH PROFILE PUBLIC HEALTH Today, as new food and water-related risks continue to emerge, and at a time when the relationships between infectious diseases, cancer and
More informationCorporate Medical Policy. Policy Effective January 1, 2019
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intra_articular_hyaluronan_injections_for_treatment_of _osteoarthritis_of_the_knee 12/1997 6/2018 6/2019
More information